Management of Recurrent Vancomycin-resistant Enterococcus faecium Bacteremia With Oritavancin: A Case Report
In Vivo · 2024
DOI: 10.21873/invivo.13795 ↗Kurz gefasst
Fallbericht in der Zeitschrift In Vivo, 2024. Verfasst von Samuel Jalali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal and Hospital Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, U.S.A.; Samuel.Jalali@moffitt.org. Hauptthemen laut MEDLINE: Lipoglycopeptides, Bacteremia, Enterococcus faecium, Vancomycin-Resistant Enterococci. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal and Hospital Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, U.S.A.; Samuel.Jalali@moffitt.org.
- Department of Internal and Hospital Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, U.S.A.
- Department of Pharmacy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, U.S.A.
Zitieren
APA
Jalali, S., Bhatt, H., Thakkar, K., Julka, R., Pasikhova, Y., & Verma, N. (2024). Management of Recurrent Vancomycin-resistant Enterococcus faecium Bacteremia With Oritavancin: A Case Report. In Vivo. https://doi.org/10.21873/invivo.13795
Vancouver
Jalali S, Bhatt H, Thakkar K, Julka R, Pasikhova Y, Verma N. Management of Recurrent Vancomycin-resistant Enterococcus faecium Bacteremia With Oritavancin: A Case Report. In Vivo. 2024. doi:10.21873/invivo.13795
BibTeX
@article{Jalali2024,
author = {Jalali, Samuel and Bhatt, Hetanshi and Thakkar, Keval and Julka, Rohan and Pasikhova, Yanina and Verma, Neha},
title = {Management of Recurrent Vancomycin-resistant Enterococcus faecium Bacteremia With Oritavancin: A Case Report},
journal = {In Vivo},
year = {2024},
doi = {10.21873/invivo.13795}
}
EUVIMED